A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Malignant Solid Tumors

Interventions

DRUG

SHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin

Trial Locations (1)

RECRUITING

Affiliated Cancer Hospital of Shandong First Medical University, Jinan

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY

NCT07028281 - A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors | Biotech Hunter | Biotech Hunter